Clinicopathological features and prognostic analysis of Her-2-negative breast mucinous adenocarcinoma: A SEER database analysis

Abstract

Background Breast mucinous adenocarcinoma is a group of malignant tumors of epithelial origin of the breast with a good prognosis; however, whether its treatment regimen should be consistent with that of non-specific types of breast cancer remains to be investigated. Methods In this study, the clinicopathological information, treatment modalities, and prognosis of 10,466 patients with mucinous adenocarcinoma of the breast from the Surveillance, Epidemiology, and End Results (SEER) database were analyzed. Results After adjusting for other factors, radiotherapy showed a favorable benefit in most subgroups; although this may be associated with a higher proportion of breast-conserving surgery in early cases, chemotherapy did not show any benefit. In particular, estrogen receptor-negative subgroup patients who received chemotherapy had a poorer prognosis. Conclusions Although derived from retrospective studies, the results of these analyses revealed trends that may warrant further study.